These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 13172694

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Azaserine resistance in a plasma-cell neoplasm without change in active transport of the inhibitor.
    ANDERSON EP, JACQUEZ JA.
    Cancer Res; 1962 Jan; 22():27-37. PubMed ID: 13861221
    [No Abstract] [Full Text] [Related]

  • 26. Azaserine: microbiological studies.
    COFFEY GL, HILLEGAS AB, KNUDSEN MP, KOEPSELL HJ, OYAAS JE, EHRLICH J.
    Antibiot Chemother (Northfield); 1954 Jul; 4(7):775-91. PubMed ID: 24543177
    [No Abstract] [Full Text] [Related]

  • 27. [On the effect of azaserine and azaserine with 6-mercaptopurine on the Yoshida sarcoma].
    YAMAGUCHI H, KURAHORI T, KUSUMOTO G, TERASHITA N, TABUCHI Y, ICHIHARA G, TOKITA Y, IKEDA E, FUKUI S.
    Gan; 1956 Dec; 47(3-4):385-6. PubMed ID: 13415049
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The effect of azaserine and 6-diazo-5-oxo-L-norleucine on the biosynthesis of inosinic acid de novo.
    BUCHANAN JM.
    Tex Rep Biol Med; 1957 Dec; 15(1):148-53. PubMed ID: 13409287
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Azaserine: pathological and pharmacological studies.
    STERNBERG SS, PHILIPS FS.
    Cancer; 1957 Dec; 10(5):889-901. PubMed ID: 13472634
    [No Abstract] [Full Text] [Related]

  • 32. Concentrative uptake of azaserine by neoplastic plasma cells and lymphocytes.
    PINE EK.
    J Natl Cancer Inst; 1958 Nov; 21(5):973-84. PubMed ID: 13599021
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Active transport of O-diazoacetyl-L-serine and 6-diazo-5-oxo-L-norleucine in Ehrlich ascites carcinoma.
    JACQUEZ JA.
    Cancer Res; 1957 Oct; 17(9):890-6. PubMed ID: 13472680
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Resistance in L1210 ascites without change in concentrative uptake of o-diazoacetyl-L-serine or 6-diazo-5-oxo-L-norleucine.
    JACQUEZ JA, HUTCHISON DJ.
    Cancer Res; 1959 May; 19(4):397-401. PubMed ID: 13652124
    [No Abstract] [Full Text] [Related]

  • 37. The influence of azaserine and 6-mercaptopurine on the in vivo metabolism of ascites tumor cells.
    FERNANDES JF, LEPAGE GA, LINDNER A.
    Cancer Res; 1956 Feb; 16(2):154-61. PubMed ID: 13293657
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Antitumor activity of N-diazoacetyl derivatives of glycine and phenylalanine against P388 leukemia and B16 melanoma in mice.
    Sava G, Giraldi T, Baldini L.
    Cancer Treat Rep; 1982 Jan; 66(1):179-81. PubMed ID: 6796268
    [Abstract] [Full Text] [Related]

  • 40. Studies on cell growth and cell division. II. Selective activity of chloramphenicol and azaserine on cell growth and cell division.
    LEE KH, YUZURIHA YO, EILER JJ.
    J Am Pharm Assoc Am Pharm Assoc; 1959 Aug; 48(8):470-3. PubMed ID: 13672846
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.